RG
NKTR icon

Rathbones Group’s Nektar Therapeutics NKTR Stock Holding History

Rathbones Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-680
Closed -$182K – 359
2020
Q1 		$182K Hold
680
– – 0.01% 289
2019
Q4 		$220K Hold
680
– – 0.01% 301
2019
Q3 		$186K Hold
680
– – 0.01% 306
2019
Q2 		$363K Hold
680
– – 0.01% 251
2019
Q1 		$343K Hold
680
– – 0.01% 251
2018
Q4 		$335K Hold
680
– – 0.01% 247
2018
Q3 		$622K Hold
680
– – 0.02% 206
2018
Q2 		$498K Sell
680
-353
-34% -$407K 0.02% 213
2018
Q1 		$1.65M Sell
1,033
-20
-2% -$25.8K 0.07% 139
2017
Q4 		$944K Sell
1,053
-134
-11% -$79.3K 0.04% 178
2017
Q3 		$427K Hold
1,187
– – 0.02% 223
2017
Q2 		$348K Hold
1,187
– – 0.02% 236
2017
Q1 		$418K Hold
1,187
– – 0.02% 224
2016
Q4 		$218K Buy
1,187
+134
+13% +$27.2K 0.01% 274
2016
Q3 		$271K Sell
1,053
-134
-11% -$34.5K 0.01% 253
2016
Q2 		$253K Buy
1,187
+47
+4% +$10.5K 0.01% 249
2016
Q1 		$235K Hold
1,140
– – 0.01% 252
2015
Q4 		$235K Hold
1,140
– – 0.01% 255
2015
Q3 		$187K Buy
1,140
+133
+13% +$23.5K 0.01% 277
2015
Q2 		$189K Hold
1,007
– – 0.01% 294
2015
Q1 		$166K Hold
1,007
– – 0.01% 306
2014
Q4 		$234K Hold
1,007
– – 0.02% 275
2014
Q3 		$182K Hold
1,007
– – 0.01% 279
2014
Q2 		$194K Hold
1,007
– – 0.01% 266
2014
Q1 		$183K Hold
1,007
– – 0.01% 261
2013
Q4 		$171K Buy
1,007
+287
+40% +$46.3K 0.02% 188
2013
Q3 		$113K Hold
720
– – 0.01% 246
2013
Q2 		$125K Buy
+720
New +$110K 0.02% 224

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Rathbones Group's NKTR Position: Q2 2020 in Review

Rathbones Group sold out of Nektar Therapeutics (NKTR) in Q2 2020, closing a stake of 680 shares — an estimated $182K sold.

Rathbones Group first reported a position in NKTR in Q2 2013 and held it in 28 quarters. The position peaked at $1.65M in Q1 2018. 259 funds tracked by Wall St. Rank hold NKTR as of Q2 2020.

  • Rathbones Group reported no remaining Nektar Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Rathbones Group sold 680 Nektar Therapeutics shares in Q2 2020, an estimated $182K.
  • Rathbones Group first reported a position in Nektar Therapeutics in Q2 2013 and held it in 28 quarters.
  • Rathbones Group's Nektar Therapeutics position peaked at $1.65M in Q1 2018.
  • 259 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2020.

Based on Rathbones Group's 13F filing for Q2 2020, filed 7 Aug 2020.